LAMP2 and amyotrophic lateral sclerosis: The results showed 18.6% lower co-localization of LAMP2 and MTCO2 in the NeuN+ neurons of ALS patients than in healthy controls, suggesting significant impairment of mitophagy (Fig. 4C,D).